Angiotensin 1–7 Modulates the Dynamics and Activation of the Proto‐Oncogene Mas Receptor
Journal of Molecular Recognition · 2026-05 · 39 (3)
DOI: 10.1002/jmr.70031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Recognition, online erschienen am 15.03.2026. Verfasst von Ekrem Yasar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biophysics, Erzincan Binali Yildirim University, Erzincan, Turkey. Hauptthemen laut MEDLINE: Angiotensin I, Peptide Fragments, Receptors, G-Protein-Coupled, Proto-Oncogene Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: Akdeniz University Scientific Research Projects Fund.
Abstract (Originalsprache)
The proto‐oncogene Mas receptor (MasR) is a class‐A (orphan‐type) G protein‐coupled receptor (GPCR) that mediates the cardioprotective effects of Angiotensin 1–7 (Ang 1–7) within the renin–angiotensin system (RAS). Despite its therapeutic relevance, the molecular mechanisms underlying MasR activation remain elusive due to the lack of experimental structural data. In this study, we combined 1‐μs all‐atom molecular dynamics (MD) simulations of AlphaFold‐modeled MasR with energetic network analyses to elucidate ligand‐induced activation dynamics. Our results challenge the conventional electrostatic clamp model, revealing a distinct active anchor mechanism. We demonstrate that Ang 1–7 releases the inactive core lock (ARG245–TYR248) to engage a critical anchor cluster (SER109/PHE112). This interaction stabilizes a unique decoupled conformational state: while the NPxxY motif is fully activated and the intracellular vestibule expands via noncanonical communication hubs that substitute for the absent conserved microswitches, TM6 remains in a restricted, compact conformation (~10 Å). Thermodynamically, this partial activation is supported by favorable computed binding energetics and enhanced conformational plasticity. These findings provide a structural rationale for the partial agonist profile of Ang 1–7 and offer a transformative mechanistic framework for therapeutic targeting of the ACE2/Ang 1–7/MasR axis. We propose that rational drug design need not aim for maximal receptor opening; instead, strategies focusing on peptidomimetics or positive allosteric modulators (PAMs) that stabilize this specific compact active state could selectively potentiate protective RAS signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biophysics, Erzincan Binali Yildirim University, Erzincan, Turkey.
- Department of Medical Biochemistry, Akdeniz University Medical School, Antalya, Turkey.
- Department of Mathematics and Science Education, Akdeniz University, Antalya, Turkey.
- Department of Biophysics, Akdeniz University Medical School, Antalya, Turkey.
ORCID-Profile: Ekrem Yasar, Nazmi Yaras
Förderung
- Akdeniz University Scientific Research Projects Fund
Zitieren
APA
Yasar, E., Dogru, S., Eroglu, E., & Yaras, N. (2026). Angiotensin 1–7 Modulates the Dynamics and Activation of the Proto‐Oncogene Mas Receptor. Journal of Molecular Recognition, 39(3). https://doi.org/10.1002/jmr.70031
Vancouver
Yasar E, Dogru S, Eroglu E, Yaras N. Angiotensin 1–7 Modulates the Dynamics and Activation of the Proto‐Oncogene Mas Receptor. Journal of Molecular Recognition. 2026;39(3). doi:10.1002/jmr.70031
BibTeX
@article{Yasar2026,
author = {Yasar, Ekrem and Dogru, Segun and Eroglu, Erol and Yaras, Nazmi},
title = {Angiotensin 1–7 Modulates the Dynamics and Activation of the Proto‐Oncogene Mas Receptor},
journal = {Journal of Molecular Recognition},
year = {2026},
volume = {39},
number = {3},
doi = {10.1002/jmr.70031}
}
EUVIMED